Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001048477-24-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $0.00 | +10.6K | 98.8K | +12% | $0 |
| D | 2024-03-19 | 2024-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | F - Tax | $83.87 | -20.4K | 78.3K | -21% | -$1.71M |
| D | 2024-03-19 | 2024-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $0.00 | +23.6K | 23.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 10,550 | $0.00 | 98,751 | D | — | — | (F1) Restricted stock units granted March 15, 2024. Price not applicable. |
| 2 | Common | Common Stock | 2024-03-15 | F | D | 20,424 | $83.87 | 78,327 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-03-15 | A | A | 23,630 | $0.00 | 23,630 | D | $83.87 · 2025-03-15 to 2034-03-14 | 23,630 Common Stock | (F2) Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter. |